FMR LLC 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 11:30 am Purchase | 2026-03-31 | 13G | NURIX THERAPEUTICS INC NRIX | FMR LLC | 5,541,271 5.400% | 1,381,331 (+33.21%) | Filing |
| 2025-11-07 11:13 am Sale | 2025-10-31 | 13G | NURIX THERAPEUTICS INC NRIX | FMR LLC | 4,159,940 4.100% | -4,627,597 (-52.66%) | Filing |
| 2025-11-05 11:40 am Sale | 2025-09-30 | 13G | NURIX THERAPEUTICS INC NRIX | FMR LLC | 8,787,537 11.500% | -1,458,674 (-14.24%) | Filing |
| 2025-05-12 10:36 am Sale | 2025-03-31 | 13G | NURIX THERAPEUTICS INC NRIX | FMR LLC | 10,246,211 13.400% | -60,140 (-0.58%) | Filing |
| 2024-12-06 11:34 am Purchase | 2024-11-29 | 13G | NURIX THERAPEUTICS INC NRIX | FMR LLC | 10,306,351 14.500% | 10,306,351 (New Position) | Filing |